Investment and M&A transaction comps
CPG Investment & M&A Transaction Comps
Global CPG and consumer brand investments, capital raises and M&A transactions, including food, beverage, beauty, personal care, supplements and adjacent branded consumer categories.
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 10 | 9 | 4.0x | 9.9x |
| 2025 | 14 | 14 | 3.3x | 12.7x |
| 2024 | 12 | 11 | 3.6x | 16.0x |
| 2023 | 20 | 18 | 4.0x | 20.9x |
| 2022 | 20 | 10 | 4.9x | 20.4x |
| 2021 | 25 | 20 | 4.7x | 15.2x |
| 2020 | 15 | 10 | 4.2x | 14.7x |
| 2019 | 8 | 7 | 4.3x | 17.4x |
Sortable transaction comps
CPG transaction table
Rows with reported value
9 / 10
Acquisition EV, USD
USD 5.5B
Investment EV, USD
USD 14.2M
Median EV / revenue
3.9x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
10 shown of 10 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ultra Violette Capital Raise | 2024-01-23 | Aria Growth Partners | AUD 15.0M Investment Amount | 10 | - | - | Australia | Confirmed 1 source | ||
| Go-To Skincare Control (50%) | 2023-12-15 | Zoë Foster Blake | AUD 43.5M Enterprise Value | 29 | - | - | Australia | Confirmed 2 sources | ||
| Straand Capital Raise | 2023-12-10 | Unilever Ventures | USD 4.0M Investment Amount | 4 | - | - | Australia | Confirmed 1 source | ||
| Bondi Sands Control | 2023-08-01 | Kao Corporation | AUD 450M Consideration | 298 | 4.2x | - | Australia | Confirmed 1 source | ||
| Blackmores Control (100%) | 2023-04-26 | Kirin | USD 1.2B Enterprise Value | 1,241 | 2.9x | 23.1x | Australia | Estimated 3 sources | ||
| Aesop Control | 2023-04-03 | L’Oréal | EUR 2.2B Consideration | 2,500 | 4.4x | 24.7x | Australia | Confirmed 2 sources | ||
| NAK Hair Control | 2022-05-01 | Adamantem Capital | AUD 90.0M | 65 | 2.3x | - | Australia | Estimated 1 source | ||
| Go-To Skincare Control (50%) | 2021-03-01 | BWX | AUD 177M Enterprise Value | 137 | 4.8x | 14.9x | Australia | Estimated 3 sources | ||
| Swisse Control (83%) | 2015-09-17 | Biostime | AUD 1.7B Enterprise Value | 1,197 | 3.6x | 10.2x | Australia | Confirmed 2 sources | ||
| MADE Group Control (49%) | - | Danone | Undisclosed | Undisclosed | - | - | Australia | Confirmed 1 source |